Web Date: March 27, 2012
Supreme Court Orders Review Of Gene Patents
On Monday, the Supreme Court set aside an appeals court ruling that allows human genes to be patented and ordered that court to rehear the case.
The justices instructed the U.S. Court of Appeals for the Federal Circuit, in Washington, D.C., to reconsider its July 29, 2011, decision that allowed patents on two “isolated” human genes used in tests for breast and ovarian cancer developed by Myriad Genetics, a biotech . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society